Physician profile
John M Travaline
NPI 1417945460
$1,465.33
in general payments reported to CMS, 2019-2025
7 companies · $59.34 in 2025
The $59.34 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,022 · 2023: $280 · 2024: $103 · 2025: $59.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323 · Travel and Lodging: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.82 |
| Travel and Lodging | $120.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,094.85 | 2022-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Harmony Biosciences LLC | $272.75 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $28.10 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $19.38 | 2023 | Uptravi, Opsumit |
| Cardinal Health 200 LLC | $17.93 | 2023 | |
| Resmed Corp | $16.76 | 2023 | |
| Insmed, INC. | $15.56 | 2023 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Travaline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.